Boots' US parent company, Walgreens Boots Alliance, said Simon Roberts would be leaving in July “to pursue new opportunities” after 13 years with the company - the last three as President of Boots.
A recent investigation by The Guardian caused scandal after it was revealed managers were directing their pharmacists to provide medicine-use reviews (MUR) to customers who did not need them, in order to claim public money from the NHS.
The NHS pays £28 for each MUR; which is carried out by a pharmacist and intended to give patients professional advice on health, diet and how to manage their medicines.
The company’s pharmacists also alleged that a drive to cut costs was endangering patients and putting the pharmacists themselves under unreasonable pressure – in some cases affecting their own health.
Continue reading for FREE!
Sign up for a myGrapevine account to get:
- Unlimited access to News content
- The latest Features, Columns & Opinions
- A full range of specialist HR newsletters to choose from
UK
United States

